Company Monitoring Page for MorphoSys

latest headlines for company on cafepharma

MorphoSys tanks after Celgene walks away from $818M pact
Fierce Biotech
Fri, 03/27/15 - 10:13 am
Tags:
MorphoSys, Celgene, Multiple Myeloma
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Yahoo/PR Newswire
Sun, 12/7/14 - 10:08 am
Tags:
MorphoSys, Xencor, MOR208, chronic lymphocytic leukemia, leukemia
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
Sat, 11/8/14 - 11:39 am
Tags:
diffuse large B-cell lymphoma, lymphoma, MorphoSys, MOR208
Novartis aims to show strength with muscle wasting drug
Yahoo/Reuters
Fri, 12/6/13 - 10:24 am
Tags:
muscle wasting, Novartis, sporadic inclusion body myositis, BYM338, MorphoSys
MorphoSys Plans to Raise Spending on Immunotherapy Treatments
Bloomberg
Thu, 08/1/13 - 08:42 am
Tags:
MorphoSys, immunotherapy
Watch Out for These 3 Biotech Companies
Motley Fool
Thu, 07/4/13 - 11:23 am
Tags:
Biogen Idec, Biocad, Amgen, M&A, Celgene, MorphoSys, Tecfidera
MorphoSys Rises on $818 Million Drug Alliance
Bloomberg
Thu, 06/27/13 - 10:41 am
Tags:
MorphoSys, MOR202, Celgene, Multiple Myeloma
Is This GlaxoSmithKline's Next Big Blockbuster?
Motley Fool
Fri, 06/7/13 - 05:47 pm
Tags:
rheumatoid arthritis, GSK, Humira, AbbVie, MOR103, MorphoSys
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Tags:
Arqule, Array Biopharma, Celldex, Aveo Pharmaceutical, Curis, Exelixis, MorphoSys, Genmab, Novartis, Incyte, Seattle Genetics, YM BioSciences
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
MorphoSys Chief Says MOR103 Drug Data Makes Deal More Likely
Bloomberg
Fri, 09/21/12 - 11:35 am
Tags:
MorphoSys, MOR103, rheumatoid arthritis
Morphosys, Merck & Co. Sign Pact for HuCAL in Vaccine Research
Bloomberg
Mon, 08/1/11 - 10:17 am
Tags:
vaccines, MorphoSys, Merck, HuCAL
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tue, 03/15/11 - 12:31 pm
Tags:
Alzheimer's disease, Razadyne, Nivalin, Ortho-McNeil-Janssen, Exelon, Novartis, Aricept, Eisai, Pfizer, Namenda, Merz, Forest Labs, Eli Lilly, Elan, JNJ, Roche, MorphoSys
Morphosys' Growth Story Remains Intact
Seeking Alpha
Mon, 03/7/11 - 11:42 am
Tags:
MorphoSys, Immunogen, Micromet, Novartis
MorphoSys Reports Clinical Milestones in Pfizer, OncoMed Pacts
Bloomberg
Mon, 01/31/11 - 07:53 am
Tags:
MorphoSys, Pfizer, OncoMed
MorphoSys, Daiichi Sankyo Enter Alliance to Develop Antibodies
Bloomberg
Tue, 10/20/09 - 09:07 am
Tags:
antibody discovery, MorphoSys, Daiichi Sankyo
BioElectronics Announces Completion of Clinical Study -- Preparing FDA 510(K) Pre-Marketing Notifica
PR-USA.net
Sun, 08/30/09 - 09:49 am
Tags:
MorphoSys

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.